Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis
-
- Benjamin Goeppert
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
-
- Damian Stichel
- Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
-
- Reka Toth
- Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
-
- Sarah Fritzsche
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
-
- Moritz Anton Loeffler
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
-
- Anna Melissa Schlitter
- Institute of Pathology, Technische Universitat of Munich, Munich, Germany
-
- Olaf Neumann
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
-
- Yassen Assenov
- Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
-
- Monika Nadja Vogel
- Diagnostic and Interventional Radiology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany
-
- Arianeb Mehrabi
- Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
-
- Katrin Hoffmann
- Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
-
- Bruno Köhler
- Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
-
- Christoph Springfeld
- Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
-
- Dieter Weichenhan
- Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
-
- Christoph Plass
- German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany
-
- Irene Esposito
- Institute of Pathology, Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany
-
- Peter Schirmacher
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
-
- Andreas von Deimling
- Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
-
- Stephanie Roessler
- Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
書誌事項
- 公開日
- 2021-01-19
- 権利情報
-
- http://creativecommons.org/licenses/by-nc/4.0/
- DOI
-
- 10.1136/gutjnl-2020-322983
- 公開者
- BMJ
この論文をさがす
説明
<jats:sec> <jats:title>Objective</jats:title> <jats:p>A detailed understanding of the molecular alterations in different forms of cholangiocarcinogenesis is crucial for a better understanding of cholangiocarcinoma (CCA) and may pave the way to early diagnosis and better treatment options.</jats:p> </jats:sec> <jats:sec> <jats:title>Design</jats:title> <jats:p>We analysed a clinicopathologically well-characterised patient cohort (n=54) with high-grade intraductal papillary (IPNB) or tubulopapillary (ITPN) neoplastic precursor lesions of the biliary tract and correlated the results with an independent non-IPNB/ITPN associated CCA cohort (n=294). The triplet sample set of non-neoplastic biliary epithelium, precursor and invasive CCA was analysed by next generation sequencing, DNA copy number and genome-wide methylation profiling.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p> Patients with invasive CCA arising from IPNB/ITPN had better prognosis than patients with CCA not associated with IPNB/ITPN. ITPN was localised mostly intrahepatic, whereas IPNB was mostly of extrahepatic origin. IPNB/ITPN were equally associated with small-duct and large-duct type intrahepatic CCA. IPNB exhibited mutational profiles of extrahepatic CCA, while ITPN had significantly fewer mutations. Most mutations were shared between precursor lesions and corresponding invasive CCA but <jats:italic>ROBO2</jats:italic> mutations occurred exclusively in invasive CCA and <jats:italic>CTNNB1</jats:italic> mutations were mainly present in precursor lesions. In addition, IPNB and ITPN differed in their DNA methylation profiles and analyses of latent methylation components suggested that IPNB and ITPN may have different cells-of-origin. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Integrative analysis revealed that IPNB and ITPN harbour distinct early genetic alterations, IPNB are enriched in mutations typical for extrahepatic CCA, whereas ITPN exhibited few genetic alterations and showed distinct epigenetic profiles. In conclusion, IPNB/ITPN may represent a distinctive, intermediate form of intrahepatic and extrahepatic cholangiocarcinogenesis.</jats:p> </jats:sec>
収録刊行物
-
- Gut
-
Gut 71 (2), 391-401, 2021-01-19
BMJ